These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21535730)

  • 1. Influence of dietary advanced glycation end products on wound healing in nondiabetic mice.
    Zhu Y; Lan F; Wei J; Chong B; Chen P; Huynh L; Wong N; Liu Y
    J Food Sci; 2011; 76(1):T5-10. PubMed ID: 21535730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro-prepared advanced glycation end-products and the modulating potential of their low-molecular weight degradation products in IRPTC-A rat proximal-tubular derived kidney epithelial cell line.
    Deuther-Conrad W; Franke S; Henle T; Sommer M; Stein G
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL187-96. PubMed ID: 11936867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung level of HMBG1 is elevated in response to advanced glycation end product-enriched food in vivo.
    Bartling B; Fuchs C; Somoza V; Niemann B; Silber RE; Simm A
    Mol Nutr Food Res; 2007 Apr; 51(4):479-87. PubMed ID: 17357979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycoxidation end products in commonly consumed foods.
    Goldberg T; Cai W; Peppa M; Dardaine V; Baliga BS; Uribarri J; Vlassara H
    J Am Diet Assoc; 2004 Aug; 104(8):1287-91. PubMed ID: 15281050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products.
    Zheng F; He C; Cai W; Hattori M; Steffes M; Vlassara H
    Diabetes Metab Res Rev; 2002; 18(3):224-37. PubMed ID: 12112941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of the AGEs generated from the Maillard reaction: on the relationship of food-AGEs and biological-AGEs.
    Chuyen NV
    Mol Nutr Food Res; 2006 Dec; 50(12):1140-9. PubMed ID: 17131455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
    Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
    Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice.
    Hagiwara S; Gohda T; Tanimoto M; Ito T; Murakoshi M; Ohara I; Yamazaki T; Matsumoto M; Horikoshi S; Funabiki K; Tomino Y
    Metabolism; 2009 Jul; 58(7):934-45. PubMed ID: 19427656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling.
    Kohno T; Anzai T; Naito K; Miyasho T; Okamoto M; Yokota H; Yamada S; Maekawa Y; Takahashi T; Yoshikawa T; Ishizaka A; Ogawa S
    Cardiovasc Res; 2009 Feb; 81(3):565-73. PubMed ID: 18984601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end product (AGE): characterization of the products from the reaction between D-glucose and serum albumin.
    Wu JT; Tu MC; Zhung P
    J Clin Lab Anal; 1996; 10(1):21-34. PubMed ID: 8926563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pharmacokinetics between highly and mildly modified AGE proteins in mice.
    Nagai R; Mera K; Fujiwara Y; Nagai M; Otagiri M
    Ann N Y Acad Sci; 2008 Apr; 1126():325-7. PubMed ID: 18079477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
    Susa Y; Masuda Y; Imaizumi H; Namiki A
    Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects.
    Uribarri J; Cai W; Sandu O; Peppa M; Goldberg T; Vlassara H
    Ann N Y Acad Sci; 2005 Jun; 1043():461-6. PubMed ID: 16037267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure.
    Wang LJ; Lu L; Zhang FR; Chen QJ; De Caterina R; Shen WF
    Eur J Heart Fail; 2011 Apr; 13(4):440-9. PubMed ID: 21266376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions.
    Kowluru RA
    Life Sci; 2005 Jan; 76(9):1051-60. PubMed ID: 15607333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
    Kume S; Kato S; Yamagishi S; Inagaki Y; Ueda S; Arima N; Okawa T; Kojiro M; Nagata K
    J Bone Miner Res; 2005 Sep; 20(9):1647-58. PubMed ID: 16059636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of qinghuobaiduyin on the expression of high mobility group box chromosomal protein 1 in macrophage].
    Li P; Xu D; Luo C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 35(7):766-70. PubMed ID: 20693722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum level of advanced glycation end-products (AGEs) is an independent determinant of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic general population.
    Yamagishi S; Adachi H; Takeuchi M; Enomoto M; Furuki K; Matsui T; Nakamura K; Imaizumi T
    Horm Metab Res; 2007 Nov; 39(11):845-8. PubMed ID: 17992643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products.
    Mruthinti S; Sood A; Humphrey CL; Swamy-Mruthinti S; Buccafusco JJ
    Neuroscience; 2006 Oct; 142(2):463-73. PubMed ID: 16890367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.